文献速递临床微生物质量管理与危急值

胎儿弯曲杆菌抗菌药物敏感性:参考实验室报告

Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory.
PubMed 文献 · J Clin Microbiol · 2024-02-29

该研究回顾了11年间在一家三级医疗中心和参考实验室检测的胎儿弯曲杆菌分离株的抗菌药物敏感性。采用琼脂稀释法检测环丙沙星、多西环素、红霉素、庆大霉素、美罗培南和四环素的MIC。结果显示庆大霉素和美罗培南MIC50和MIC90均为1 µg/mL,环丙沙星MIC50为1 µg/mL但MIC90>2 µg/mL,红霉素MIC50和MIC90均为2 µg/mL。

要点

  • 庆大霉素和美罗培南对胎儿弯曲杆菌显示良好MIC(MIC50和MIC90均为1 µg/mL)。
  • 环丙沙星MIC50为1 µg/mL,但MIC90>2 µg/mL,结果可变。
  • 红霉素MIC50和MIC90均为2 µg/mL。

核心结论

  • 庆大霉素和美罗培南对胎儿弯曲杆菌显示良好MIC,可作为严重感染的治疗选择,待药敏结果。
  • 环丙沙星结果可变,可能仅适合在药敏试验后使用。
  • 需要胎儿弯曲杆菌的解释标准以帮助临床医生选择经验性和确定性治疗。

研究设计与样本

  • 回顾性研究,纳入11年间Mayo Clinic及参考实验室的胎儿弯曲杆菌分离株。
  • 排除重复后,从110份阳性培养物中鉴定出105株独特分离株。
  • 采用琼脂稀释法检测环丙沙星、多西环素、红霉素、庆大霉素、美罗培南和四环素的敏感性。

主要发现

  • 血培养是最常见来源,其次为体液、皮肤软组织、中枢神经系统。
  • 庆大霉素和美罗培南的MIC50和MIC90均为1 µg/mL。
  • 环丙沙星MIC50为1 µg/mL,MIC90>2 µg/mL。
  • 红霉素MIC50和MIC90均为2 µg/mL。
  • 四环素和多西环素仅测试有限菌株,显示宽范围MIC。

关键数值与推荐

  • 庆大霉素MIC50=1 µg/mL,MIC90=1 µg/mL。
  • 美罗培南MIC50=1 µg/mL,MIC90=1 µg/mL。
  • 环丙沙星MIC50=1 µg/mL,MIC90>2 µg/mL。
  • 红霉素MIC50=2 µg/mL,MIC90=2 µg/mL。
  • 四环素和多西环素测试菌株有限,MIC范围宽。

临床怎么用

  • 庆大霉素和美罗培南可考虑用于严重胎儿弯曲杆菌感染,待药敏结果。
  • 环丙沙星应在药敏试验显示敏感后使用。
  • 目前缺乏解释标准,临床选择经验性和确定性治疗需谨慎。

局限性

  • 四环素和多西环素仅测试有限数量分离株。
  • 研究为回顾性,来自单一三级中心和参考实验室。
  • 未建立胎儿弯曲杆菌的解释标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Campylobacter fetus is known to cause human disease, particularly in elderly and immunocompromised hosts. There are limited published data for antimicrobial susceptibility patterns with this organism, and no interpretive criteria are available. We reviewed antimicrobial susceptibilities of C. fetus isolates tested at a tertiary care center and reference laboratory over an 11-year period. C. fetus isolates from patients treated at Mayo Clinic and those sent as referrals for identification and susceptibility were included. Antimicrobial susceptibility testing was performed using agar dilution for ciprofloxacin, doxycycline, erythromycin, gentamicin, meropenem, and tetracycline. Geographic distribution, culture source, organism minimal inhibitory concentration (MIC) distributions, and MIC50 and MIC90 were examined. Excluding duplicates, 105 unique isolates were identified from 110 positive cultures. Blood cultures represented the most common source, followed by body fluids, skin and soft tissue, and central nervous system. Gentamicin and meropenem had favorable MIC50 and MIC90 of 1 µg/mL. Ciprofloxacin demonstrated an MIC50 of 1 µg/mL; however, the MIC90 was >2 µg/mL. Erythromycin demonstrated MIC50 and MIC90 of 2 µg/mL. Tetracycline and doxycycline were tested on a limited number of isolates and showed a wide range of MICs. Gentamicin and meropenem demonstrated favorable MICs in C. fetus isolates. These may represent therapeutic options for consideration in serious C. fetus infections, pending susceptibility results. Ciprofloxacin, which showed variable results, may be more appropriate for use only after susceptibility testing. C. fetus interpretive criteria are needed to aid clinicians in selection of both empiric and definitive therapies. IMPORTANCE: Our findings contribute to the scant literature on Campylobacter fetus antimicrobial susceptibility test results. We used a reference test method of agar dilution and provide MICs for a large number of organisms and antimicrobial agents.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Zhang MM, Melton TA, Akhtar H, et al. Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory. J Clin Microbiol. 2024. PMID: 38421164. doi:10.1128/jcm.01447-23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。